Priya Alexander

Why is it so important to have a kind of concrete definition for this?

What will it change?

is there any kind of idea of how common these symptoms are across different cultural and ethnic groups?

So are women in different, I guess, groups reporting these cognitive symptoms of the same frequency?

So with this kind of lack of framework, you said before, we really need a concrete definition going forward.

What's the harm at the moment, Caroline, if there isn't

And also making sure it's nothing else like a thyroid disorder or iron deficiency or a mode disorder.

Where to from here?

Where do we need to go in this kind of space, I guess?

So at the moment, Caroline, what you're saying is that there's no dedicated clinical trials that have looked at menopause hormone therapy or MHT specifically for these cognitive symptoms.

And when you say cognitive training, what are we talking here?

Sudoku, crosswords or something more intense and structured?

Dr. Caroline Gervich, who's an Associate Professor and Clinical Neuropsychologist at Monash University.

I already do this stuff, but I think it might actually be validating for patients to know, you know, as Caroline says, that this is an entity, that there's no objective reduction in cognitive function.

And hopefully this leads to, as she says, better treatment options for women.

Yes.

Reduction of stigma and improvement in quality of life.

Because goodness gracious, I'm turning 40 at the end of this year, Norman.

I am.

And I'm feeling nervous because I know what women go through from sitting in the consulting room and I'm just waiting with bated breath.